Refine by
Drug Designation Software
12 software items found
by:Insilico Medicine based inPak Shek Kok, HONG KONG
Chemistry42 is an automated machine learning platform for drug design capable of finding novel lead-like structures in ...
by:Cresset Group based inCambridgeshire, UNITED KINGDOM
A single platform for ligand-based and structure-based drug design that enables research chemists to discover novel small molecules more efficiently and ...
by:Iktos based inParis, FRANCE
Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization ...
by:SilcsBio, LLC based inBaltimore, MARYLAND (USA)
The CHARMM General Force Field program generates comprehensive parameters and topology information for a wide range of drug-like molecules, allowing their use in computer-aided drug design ...
by:InterX based inBerkeley, CALIFORNIA (USA)
InterX Development Division focuses on bridging the risk gap in Drug Discovery from drug targets to novel candidates. The Development Division applies InterX’s proprietary computer-aided drug design platform, while developing collaborations with Research Centers, Pharma companies, Start-ups, Academia and Accelerators. Such ...
by:SilcsBio, LLC based inBaltimore, MARYLAND (USA)
Site-Identification by Ligand Competitive Saturation (SILCS) generates 3-D maps (FragMaps) of interaction patterns for chemical functional groups with your target ...
by:SilcsBio, LLC based inBaltimore, MARYLAND (USA)
Leading-edge software builds on the patented SILCS technology, using protein-protein interaction and excipient binding predictions to give insights on excipient formulation for biological ...
by:MasterControl, Inc based inSalt Lake City, UTAH (USA)
Small Medical Device Companies Can Now Manage and Automate their Design Control Process to Ensure Compliance with 21 CFR Part 820 with the Help of MasterControl's Design Control Software Systems at a Low Monthly Cost. Each manufactured medical device must be supported by appropriate documentation which demonstrates that its development followed the Food and ...
by:Anju Software based inTempe, ARIZONA (USA)
RTSM Master delivers powerful randomization methods that, when combined with our fully validated and configurable trial modules, can perform robust subject screening and randomization, clinical supply management and investigational product assignments at designated drug dispensing visits. RTSM Master's randomization simulator can validate and support ...
by:Simulations Plus based inLancaster, CALIFORNIA (USA)
With the ability to predict over 175 properties, it integrates seamlessly with computational chemistry and medicinal chemistry applications, offering precise predictions on solubility, logP, pKa, and sites of CYP metabolism. Enhanced through high-throughput GastroPlus® simulations, it supports the decision-making process in drug discovery and risk assessment. The platform's REST ...
by:Molecular Health GmbH based inHeidelberg, GERMANY
Reliable predictions to anticipate risks. Interlinked data to find new targets and design novel drugs. Real-world evidence to evaluate success. These capabilities eliminate the uncertainties that limit drug development but are data-intensive and experimentally inaccessible. Molecular Health Dataome Technology offers powerful solutions to ...
by:Genuity Science based inBoston, MASSACHUSETTS (USA)
We are developing novel causal artificial intelligence and machine learning (AI/ML) and unconventional computing strategies to better understand human biology – and then apply these to deliver better medicine and improve health for people around the ...